These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33890929)

  • 21. An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions.
    Pattee GL; Wymer JP; Lomen-Hoerth C; Appel SH; Formella AE; Pope LE
    Curr Med Res Opin; 2014 Nov; 30(11):2255-65. PubMed ID: 25062507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Du rire aux larmes: pathological laughing and crying in patients with traumatic brain injury and treatment with lamotrigine.
    Chahine LM; Chemali Z
    Epilepsy Behav; 2006 May; 8(3):610-5. PubMed ID: 16504590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancing Approaches to the Identification and Management of Pseudobulbar Affect.
    Crumpacker DW
    J Clin Psychiatry; 2016 Sep; 77(9):e1155. PubMed ID: 27780330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A self report measure of affective lability.
    Moore SR; Gresham LS; Bromberg MB; Kasarkis EJ; Smith RA
    J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):89-93. PubMed ID: 9221973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathological laughter and crying: insights from lesion network-symptom-mapping.
    Klingbeil J; Wawrzyniak M; Stockert A; Brandt ML; Schneider HR; Metelmann M; Saur D
    Brain; 2021 Nov; 144(10):3264-3276. PubMed ID: 34142117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward a more precise, clinically--informed pathophysiology of pathological laughing and crying.
    Lauterbach EC; Cummings JL; Kuppuswamy PS
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1893-916. PubMed ID: 23518269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behaviour, physiology and experience of pathological laughing and crying in amyotrophic lateral sclerosis.
    Olney NT; Goodkind MS; Lomen-Hoerth C; Whalen PK; Williamson CA; Holley DE; Verstaen A; Brown LM; Miller BL; Kornak J; Levenson RW; Rosen HJ
    Brain; 2011 Dec; 134(Pt 12):3458-69. PubMed ID: 22155983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudobulbar Affect in Survivors of Extreme Prematurity With Cerebellar Injury: Support for the Cerebellar Link in Pathologic Laughter and Crying.
    Bodensteiner JB
    Semin Pediatr Neurol; 2018 Jul; 26():74-76. PubMed ID: 29961526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Information/education page. Pseudobulbar affect.
    Mack E; Peters H; Page SJ
    Arch Phys Med Rehabil; 2014 Aug; 95(8):1599-600. PubMed ID: 25064417
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmaceutical interventions for emotionalism after stroke.
    House AO; Hackett ML; Anderson CS; Horrocks JA
    Cochrane Database Syst Rev; 2004; (2):CD003690. PubMed ID: 15106213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis.
    Panitch HS; Thisted RA; Smith RA; Wynn DR; Wymer JP; Achiron A; Vollmer TL; Mandler RN; Dietrich DW; Fletcher M; Pope LE; Berg JE; Miller A;
    Ann Neurol; 2006 May; 59(5):780-7. PubMed ID: 16634036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A real reason for patients with pseudobulbar affect to smile.
    Rosen HJ; Cummings J
    Ann Neurol; 2007 Feb; 61(2):92-6. PubMed ID: 17212357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Major Depressive Disorder in a Patient with Pseudobulbar Affect.
    Espiridion ED; Risos KN
    Cureus; 2018 Dec; 10(12):e3746. PubMed ID: 30820367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and neurobehavioral correlates of pathological laughing and crying in multiple sclerosis.
    Feinstein A; Feinstein K; Gray T; O'Connor P
    Arch Neurol; 1997 Sep; 54(9):1116-21. PubMed ID: 9311355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmaceutical interventions for emotionalism after stroke.
    Hackett ML; Yang M; Anderson CS; Horrocks JA; House A
    Cochrane Database Syst Rev; 2010 Feb; (2):CD003690. PubMed ID: 20166068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current concepts in the pharmacotherapy of pseudobulbar affect.
    Pioro EP
    Drugs; 2011 Jun; 71(9):1193-207. PubMed ID: 21711063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of pseudobulbar affect (PBA) in a patient with a history of traumatic brain injury, partial brain resection, and brainstem stroke: a case report.
    Young FG; Nguyen D
    J Med Case Rep; 2020 Dec; 14(1):235. PubMed ID: 33272325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of Escitalopram for pseudobulbar affect following severe traumatic.
    Amir Malik MF; Jafri MAK; Nizami AT
    J Pak Med Assoc; 2023 Feb; 73(2):416-418. PubMed ID: 36800742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The emotional lability questionnaire: a new measure of emotional lability in amyotrophic lateral sclerosis.
    Newsom-Davis IC; Abrahams S; Goldstein LH; Leigh PN
    J Neurol Sci; 1999 Oct; 169(1-2):22-5. PubMed ID: 10540003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacotherapy for the pseudobulbar affect in individuals who have sustained a traumatic brain injury: a systematic review protocol.
    Clay FJ; Hicks AJ; Perry LA; Ponsford JL; Jayaram M; Hopwood M
    JBI Database System Rev Implement Rep; 2018 Sep; 16(9):1739-1757. PubMed ID: 30204664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.